Your browser doesn't support javascript.
loading
A2ML1 Inhibits Esophageal Squamous Cell Carcinoma Progression and Serves as a Novel Prognostic Biomarker.
Zhang, Xiaoyun; Tang, Chaogui; Lian, Jianchun; Jiang, Yuzhang.
Affiliation
  • Zhang X; Department of Medical Laboratory, The Affiliated Huaian No. 1 People's Hospital of Nanjing Medical University, Nanjing, Jiangsu 223300, China.
  • Tang C; Department of Medical Laboratory, The Affiliated Huaian No. 1 People's Hospital of Nanjing Medical University, Nanjing, Jiangsu 223300, China.
  • Lian J; Department of Medical Laboratory, The Affiliated Huaian No. 1 People's Hospital of Nanjing Medical University, Nanjing, Jiangsu 223300, China.
  • Jiang Y; Department of Medical Laboratory, The Affiliated Huaian No. 1 People's Hospital of Nanjing Medical University, Nanjing, Jiangsu 223300, China.
Can J Gastroenterol Hepatol ; 2023: 5557546, 2023.
Article in En | MEDLINE | ID: mdl-37954860

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Esophageal Neoplasms / Carcinoma, Squamous Cell / Esophageal Squamous Cell Carcinoma Limits: Animals / Humans Language: En Journal: Can J Gastroenterol Hepatol Year: 2023 Document type: Article Affiliation country: Country of publication:

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Esophageal Neoplasms / Carcinoma, Squamous Cell / Esophageal Squamous Cell Carcinoma Limits: Animals / Humans Language: En Journal: Can J Gastroenterol Hepatol Year: 2023 Document type: Article Affiliation country: Country of publication: